Immunovia AB (IMMNOV) - Financials, balance sheet (quarterly)

Market closed

Access this stock data via API

Immunovia AB

Financials

Balance sheet

Fiscal date	Dec 2024	Sep 2024	Jun 2024	Mar 2024
Total assets	33.0M	63.1M	58.3M	71.0M
Current assets	28.6M	57.9M	42.4M	55.6M
Cash	—	—	—	—
Cash equivalents	—	—	—	—
Cash and cash equivalents	25.3M	54.2M	36.8M	51.2M
Other short term investments	—	—	—	—
Accounts receivable	0	0	0	0
Other receivables	3.3M	3.7M	5.6M	4.4M
Inventory	—	—	—	0
Prepaid assets	—	—	—	—
Restricted cash	—	—	—	—
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	—	—	—	—
Non current assets	4.4M	5.2M	15.9M	15.5M
Properties	—	—	—	—
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	—
Construction in progress	—	—	—	—
Leases	—	—	—	—
Accumulated depreciation	—	—	—	—
Goodwill	1.9M	2.1M	2.3M	2.4M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	—	—	—
Investments and advances	—	—	—	—
Other non current assets	—	—	—	—
Total liabilities	21.4M	24.5M	38.6M	27.3M
Current liabilities	21.4M	24.5M	38.6M	27.3M
Accounts payable	—	—	—	—
Accrued expenses	—	—	—	—
Short term debt	680K	1.5M	8.7M	8.8M
Deferred revenue	—	—	—	—
Tax payable	—	—	—	—
Pensions	—	—	—	—
Other current liabilities	15.0M	15.7M	29.9M	18.5M
Non current liabilities	0	0	0	0
Long term provisions	—	—	—	—
Long term debt	0	0	0	0
Provision for risks and charges	—	—	—	—
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	—	—	—	—
Shareholders equity
Common stock	5.1M	5.1M	2.3M	2.3M
Retained earnings	-1.1B	-1.1B	-1.1B	-1.1B
Other shareholders equity	—	—	—	—
Total shareholders equity	11.6M	38.6M	19.7M	43.7M
Additional paid in capital	1.2B	1.2B	1.1B	1.1B
Treasury stock	—	—	—	—
Minority interest	—	—	—	—